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Background. Although peer review is widely considered to be the most credible way of selecting manuscripts and improving
the quality of accepted papers in scientific journals, there is little evidence to support its use. Our aim was to estimate the
effects on manuscript quality of either adding a statistical peer reviewer or suggesting the use of checklists such as CONSORT
or STARD to clinical reviewers or both.Methodology and Principal Findings. Interventions were defined as 1) the addition of
a statistical reviewer to the clinical peer review process, and 2) suggesting reporting guidelines to reviewers; with ‘‘no
statistical expert’’ and ‘‘no checklist’’ as controls. The two interventions were crossed in a 262 balanced factorial design
including original research articles consecutively selected, between May 2004 and March 2005, by the Medicina Clinica (Barc)
editorial committee. We randomized manuscripts to minimize differences in terms of baseline quality and type of study
(intervention, longitudinal, cross-sectional, others). Sample-size calculations indicated that 100 papers provide an 80% power
to test a 55% standardized difference. We specified the main outcome as the increment in quality of papers as measured on
the Goodman Scale. Two blinded evaluators rated the quality of manuscripts at initial submission and final post peer review
version. Of the 327 manuscripts submitted to the journal, 131 were accepted for further review, and 129 were randomized. Of
those, 14 that were lost to follow-up showed no differences in initial quality to the followed-up papers. Hence, 115 were
included in the main analysis, with 16 rejected for publication after peer review. 21 (18.3%) of the 115 included papers were
interventions, 46 (40.0%) were longitudinal designs, 28 (24.3%) cross-sectional and 20 (17.4%) others. The 16 (13.9%) rejected
papers had a significantly lower initial score on the overall Goodman scale than accepted papers (difference 15.0, 95% CI: 4.6–
24.4). The effect of suggesting a guideline to the reviewers had no effect on change in overall quality as measured by the
Goodman scale (0.9, 95% CI:20.3–+2.1). The estimated effect of adding a statistical reviewer was 5.5 (95% CI: 4.3–6.7), showing
a significant improvement in quality. Conclusions and Significance. This prospective randomized study shows the positive
effect of adding a statistical reviewer to the field-expert peers in improving manuscript quality. We did not find a statistically
significant positive effect by suggesting reviewers use reporting guidelines.
Citation: Cobo E, Selva-O’Callagham A, Ribera J, Cardellach F, Dominguez R, et al (2007) Statistical Reviewers Improve Reporting in Biomedical
Articles: A Randomized Trial. PLoS ONE 2(3): e332. doi:10.1371/journal.pone.0000332
INTRODUCTION
Despite being widely accepted as the best way to filter low-quality
research, to detect flaws in scientific communications and to
improve papers with significant contributions to their fields [1–3],
peer review has also raised many criticisms [4–6]. Certainly, as
a process carried out by humans it has its weaknesses and therefore
many initiatives have been developed to improve it. For instance,
some methodological mistakes are continually repeated in
published papers and proposals that referees fail to detect or do
not consider properly, and because of this, both the development
of reporting guidelines [7–11] and the suggestion of adding
methodological experts to the referees panel have been promoted
[12] and implemented [13]. Accordingly, from what has been said,
we might have expected the existence of strong scientific evidence
in favor of peer review, but surprisingly, there have not been many
attempts to determine ‘‘with the scientific rigor they demand of
their authors’’ [14] its effect through measurable variables, and
little evidence supports its use [15,16]. Attempts to quantify its
effects cannot deal with comparisons concerning the acceptance of
reports without any intervention between submission and final
publication. In fact, due to ethical and practical considerations,
efforts have been specially made so as not to delay or interrupt the
normal screening processes, so that the only alternative for
evaluating the effects of peer review has been to assess surrogate
variables.
The suggestion of adding a methodological expert to the
reviewers pool of a Spanish biomedical journal gave us the chance
to conduct a masked, randomized experiment to assess the effect of
peer review, not only without interfering with the regular course of
the editorial process, but also describing more realistically the true
role of peer reviewing in improving the quality of papers. The two
main objectives of our investigation were to assess the effects of (1)
adding a statistical peer reviewer and (2) suggesting reporting
guidelines [17–22] to reviewers, by taking into account a direct
measurement of the final quality of papers instead of relying on
surrogate variables.
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METHODS
Setting
Medicina Clı´nica (www.doyma.es/medicinaclinica) is a peer-
reviewed weekly Spanish biomedical journal included in the
Science Citation Index, the Current Contents, the Index Medicus
and Excerpta Medica. It aims to publish original research papers,
review articles, brief clinical notes, challenging editorials and the
opinions of readers in the ‘‘letter to the editor’’ section. All
submitted original research manuscripts are first evaluated by the
journal’s editorial committee, who decide which papers meet the
journal’s criteria and standards of relevance, and which are
consequently sent for external peer-review, usually by two referees
from the journal pool who are particularly familiar with the subject
matter of the paper.
For this study, we included manuscripts sent to the ‘‘original’’
and ‘‘brief original’’ sections, which have to contain original
primary research and include statistical analysis.
Qualitative research reports, case series, editorials, non-
systematic reviews and letters to the editor were systematically
excluded from the study.
Data and allocation
Original research articles submitted consecutively to Medicina
Clı´nica between May 2004 and March 2005 were assessed for
eligibility (JMR, FC). Articles not fitting the journal’s editorial
policy were excluded.
We randomly allocated the manuscripts accepted for review
into four groups defined by the interventions: Clinical reviewers
(C) as normal procedure; Clinical reviewers plus a Statistical
reviewer (CS); Clinical reviewers with checKlist (CK); and,
Clinical reviewers plus a Statistical reviewer and checKlist
(CSK). In this fashion, group C, acting as control group, only
applied a clinical review, and therefore each article was sent to two
clinical reviewers chosen from among the usual pool used by the
journal. Papers were randomized once the two clinical peers had
been chosen. Then, those allocated to the CS set were also sent to
an expert statistical reviewer selected from the Medicina Clinica
referee pool, which includes mainly senior methodological experts
and graduate statisticians. A total of 39 methodological experts
(table 1) were employed as statistical reviewers. Due to the late
introduction, during the nineties, of formal statistical studies in
Spain, reviewers with formal academic degrees in statistics were
much younger (32.9 ( SD 2.7)) than statistical reviewers with
academic degrees from applied bio-health disciplines. Although
both authors and reviewers were warned that their material would
be used to evaluate quality improvement during the editorial
process, they were not warned about specific objectives.
Manuscripts sorted into the CK intervention group were simply
sent to the two clinical reviewers with a standard letter [‘‘To facilitate
your revision, you will find enclosed the reporting guideline from
Bosch and Guardiola (Med Clin (Barc) 2003; 121:228–30). If you
prefer, you may also employ one of the following documents: for
clinical trials, the CONSORT statement (Ann Inter Med
2001;134:663–694); for meta-analysis, QUOROM (Lancet 1999;
354: 1896–1900); for diagnostic tests, STARD (Clinical Chemistry
2003;49:7–18); or the collections provided by the Scottish In-
tercollegiate Guidelines Network (http:/www.sign.ac.uk/guidelines/
fulltext/50/annexc.html) or by Mora (Med Clin (Barc) 1999;113:
138–49’’]. Reviewers were not asked to report whether they used the
reporting guideline in reviewing the manuscript. Finally, manu-
scripts from the CSK group were defined by the use of both
interventions.
Each paper was appraised (on a 9-point Likert scale) and
classified (by EC) by study type (1: intervention, if a different
treatment than standard was given to patients; 2: longitudinal, if
observation lasted for more than one time point; 3: cross-sectional,
just one time point observation; and 4-others, if the study could
not fit into the previous groups, for example, non-human units,
population data, meta-analyses and so on). Then, manuscripts
were randomly allocated (by AS) using a computer program that
first stratifies by study type, and second allocates to intervention
groups while minimizing differences in initial quality. Then, the
manuscripts followed the proper editorial procedure, according to
their assigned group. See authors and reviewers agreement in
supporting information file S1.
Assessment and Procedure
A modified version of the Manuscript Quality Assessment
Instrument (MQAI) designed by Goodman et al. (see supporting
information file S2) [23] was used to assess the outcome. Each item
assessed quality using a 5-point Likert scale from 1 (low) to 5
(high). Two specific items were added: one related to misconduct
(item 1b), which includes suspicion of forgery, and one related to
sample-size calculations (item 4b).
Two evaluators (EC, RD) independently rated the reporting
quality of manuscripts at initial submission and following peer
review and revision, according to the MQAI. Both knew the initial
and final status but were blinded to the intervention group. The
final score awarded to each scale item was reached by averaging
the two evaluators’ item scores after allowing each one to modify
his or her score once the reasons for the other evaluator’s score
was made known. Primary outcome was defined as the difference
in the quality of papers between the initial and final submission,
expressed as the sum of the 36 specific MQAI items, resulting in
a minimum of 36 (lowest quality) and a maximum of 180 points.
In order to evaluate the success of masking, the evaluators tried
to guess which papers had been revised by a statistical reviewer (or
with the help of a guideline) from the changes they observed in
each article. The evaluators had to answer the following question
by consensus: ‘‘Has it been reviewed by a statistician (or with the
Table 1. Statistical reviewers (n = 39) characteristics.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Academic degree N (%)
Technical 21 (53.8%)
Statistics 16 (41.0%)
Mathematics 3 (7.7%)
Engineering 2 (5.1%)
Applied 18 (46.2%)
Medicine 13 (33.3%)
Biology 3 (7.7%)
Psychology 2 (5.1%)
Current Employment N (%)
Universities 16 (41.0%)
Non profit organization 16 (41.0%)
Profit organizations 7 (17.9%)
Min Max Mean SD
Age 29 64 41.5 9.1
Previous years reviewing MedClin (Barn) 2 10 5.0 1.5
Previous performed reviews 1 18 5.3 3.5
doi:10.1371/journal.pone.0000332.t001..
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help of a guideline)?’’ The possible answers were ‘‘Yes’’, ‘‘No’’ and
‘‘I don’t know’’. The blinding process was analyzed and
considered successful if the evaluators’ hit-proportion was not
bigger than that expected by chance (50%). The cases with an
answer ‘‘I don’t know’’ were not included in the analysis. Only
after the results had been validated and introduced into the
database, was the group corresponding to each article revealed to
the evaluators so that they could carry out the analysis.
Study populations
Three different populations were considered: ‘‘complete’’ which
included all randomized manuscripts not lost to follow-up, which
was the population for the main analysis. Two other populations
were defined for the sensitive analyses: one taking into consideration
all ‘‘randomized’’ manuscripts and one including only those
manuscripts accepted for publication. Those manuscripts rejected
due to reviewers’ comments and those lost to follow-up were
analyzed considering two different values for their final quality: 1) the
initial overall quality was imputed as the final overall quality
interpreted as no change in quality during the editorial process), or 2)
the final overall quality was assigned a value equal to the mean final
quality value of the final versions of the received articles. The second
method accounted for the positive effects of rejecting the low quality
manuscripts, since the lower the initial score of the manuscript, the
better the score in the initial-final difference assigned.
Analysis and Sample Rationale
A 262 analysis of variance of the primary variable (change in
quality score) was carried out to test the two hypotheses: 1, adding
a statistical reviewer to the field expert peers and 2, suggesting
reviewers reporting guidelines. Since both hypotheses addressed
different objectives, no adjustment of the alpha risk consumption
was made. Sample-size calculations indicated that a hundred
articles were needed to reach an 80% power to detect a difference
in means equivalent to a 55% of the intra-group standard
deviation (a= 0.05; two-sided testing).
Secondary analysis were also based on ANOVA and included
the same comparison of quality improvement by each individual
item, as well as the segregated analysis of the rejected manuscripts
and comparisons of initial quality between the originals that
completed the editorial process and those which were lost to
follow-up, by means of t-tests and x2 tests. To check the effective-
ness of the masking procedure, the percentage of matched trials
between the appraisers’ assessment and the real allocation of each
article was computed. The main analysis was repeated stratifying
by response to the masking question in order to analyze if it was
able to account for the intervention effect.
RESULTS
Enrolment and Randomization
Of the 327 originals received between May 2004 and March 2005,
196 (59.9%) were directly rejected by the editorial team. The
remaining 131 (40.1%) were selected by the editorial committee as
possible publications and therefore randomized. Of these, 2 were
excluded either as a result of an administrative error (n = 1) or
because the authors refused to participate (n = 1). From the 129
randomized manuscripts, 14 were lost of follow up because
authors missed the deadline and the masked allocation was
revealed; 21 (18.3%) of the 115 included papers were ‘‘interven-
tions’’, but only 3 were randomized clinical trials, 46 (40.0%) were
longitudinal designs, 28 (24.3%) cross-sectional and 20 (17.4%)
others. On the other hand, 16 were rejected by the editorial team
after evaluating peer-review reports. The rejected papers had
a significantly lower initial score on the overall Goodman scale than
the accepted papers (difference 15.0, 95% CI from 4.6 to 24.4). No
significant differences in initial quality were found between the lost
to follow-up articles and the ones studied. Figure 1 shows the
distribution of manuscripts among randomization groups.
Descriptive Analysis of Initial Quality
The initial mean overall quality of the 115 originals analyzed was
84.5 (SD 19.1), without significant differences between the inter-
vention groups. Table 2 shows baseline overall Goodman’s scale
by study type and allocated intervention group and Table 3 shows
the baseline characteristics for each item by intervention group. In
general, the manuscripts classified as ‘‘others’’, followed by those
reporting interventions, showed the lowest scores while, on
average, longitudinal designs rated above the other types of study.
Effects on the Primary Outcome
Figure 2 shows confidence intervals for the change between initial
and final values in the four randomized groups. The estimated
effect (fig. 3) of adding a statistical reviewer was 5.5 (95% CI from
4.3 to 6.7) and the effect of sending a guideline to the authors was
0.9 (95% CI from 20.3 to +2.1) with no significant interaction
effect between them (1.1, 95% CI from 20.1 to +2.3). Adding
a statistical reviewer had a reasonably homogeneous effect among
the four study types (fig. 3), but the suggestion of employing
a checklist had a negative effect on the group of intervention
papers. In the sensitive-analyses populations, we reached the same
conclusions about those effects. Referring to the impact of non-
complete data, the 14 papers lost to follow-up had a heterogeneous
distribution among the randomized groups (figure 1) but did not
differ, in terms of baseline quality, from the originals in the
accepted manuscripts population. We performed several sensitivity
analyses including those papers with different imputed values for
the final version that produced very similar conclusions.
Effects by each Individual Item
Figure 4 highlights the results for those items in which the effect of
adding a statistician was found to be statistically significant. The
by-item analysis showed a significant effect due to statistical review
in 10 items. Individually, the items related to ‘‘quantitative
methods’’ (effect size 0.50, [95% CI] from 0.23 to 0.77), ‘‘clear
reporting’’ (0.49, from 0.27 to 0.70), ‘‘design’’ (0.41, from 0.17 to
0.64), and ‘‘reporting multiple measures’’ (0.38, from 0.12 to 0.65),
were those where, on average, the statistical review most raised the
Table 2. Initial overall quality scores by study type, as assessed
by two blinded evaluators on the Goodman scale.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
INITIAL OVERALL QUALITY SCORES
Group C CS CK CSK ALL
Outcome N Mean N Mean N Mean N Mean N Mean
TOTAL 32 81.0 30 81.0 28 88.8 25 88.2 115 84.5
1. Intervention 4 76,5 7 84,1 4 110,3 6 69,8 21 83,6
2. Longitudinal 14 84,6 10 86,5 12 86,9 10 93,6 46 87,6
3. Cross-sectional 9 85,9 8 71,5 6 93,0 5 90,2 28 84,1
4. Other 5 65,6 5 81,0 6 74,0 4 99,8 20 78,8
Overall score is computed as the sum over the 36 individual items, each one
rated from 1 (lowest) to 5 (highest). Minimum and maximum possible overall
scale values were 36 and 180. Standard deviation was 19.
doi:10.1371/journal.pone.0000332.t002..
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quality of the submitted manuscript. Peer review by a statistician
also had an impact on quality in items concerning the addition
of ’’oversight or fake’’, ‘‘figures and tables’’, ‘‘diagnostic tests’’,
‘‘power’’, ‘‘organization’’ and ‘‘style’’. In contrast, the use of a
recommended checklist by reviewers (Fig. 5) was positively signifi-
cant in only 2 items; ‘‘major variables’’ and ‘‘sample description’’,
although 2 items had negative significant effects: ‘‘clear reporting’’
and ‘‘generalizing’’.
Successful Masking
On the ‘‘presence of a statistical reviewer’’ question, 20 (20.2%)
originals were evaluated as ‘‘I don’t know’’. The remaining 79
originals (79.8%) were inspected with a match percentage of
60.8% (95% CI from 49.1 to 71.6%). On the use of a checklist, the
evaluators were able to guess the intervention group in 65.3%
(95% CI from 53.5 to 76.0%) of the 75 over 99 (75.8%) cases
analyzed. The remaining 24 (24.2%) were evaluated as ‘‘I don’t
know’’. After stratifying by response to both of the blinding
questions, the overall conclusion on the main effects remained the
same (statistical reviewer effect = 5.9, 95% CI = 3.4 to 8.5;
checklist effect =21.43, 95% CI =23.8 to 0.99).
DISCUSSION
We have shown that the addition of a supplementary statistical
reviewer improves manuscript quality during the editorial process.
As the control intervention was ‘‘two clinical reviewers’’, the
Figure 1. Flow chart of the review process among the four randomization groups. From 131 selected papers for possible publication, 129 were
randomized and allocated into four comparison groups in a 262 factorial design to evaluate the effects of adding a statistical expert as a reviewer
and of suggesting the use of checklists. Main analyses are based on the 115 papers which completed the review process.
doi:10.1371/journal.pone.0000332.g001
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estimated effect can be imputed either to the addition of an extra
reviewer, or to the inclusion of a statistical expert, both of which
confirm that peer review improves overall quality as measured by
the MQAI. This result is consistently sustained by the alternative
analysis of the sensitive populations. The guess (yes/no/don’t
know) of the statistician intervention was not able to remove the
observed effect.
The size of the effect found can be interpreted in terms of
specific item improvement: the 5.5 effect value counts as a 1-point
quality improvement in a 5-point scale on more than five specific
items. Although this effect is significant and positive, its size is very
small related to the scale range (3.8%) but medium size (85.9%)
related to the improvement variability (6.4), which may be due to
some prudence or cautiousness during masked evaluation. In any
case, in the light of the two evaluator scores, there is still room for
improvement.
Mainly because it is not easy to check peer review without
interfering with the editorial process, but also because it is con-
sidered a self-evident idea, the scientific testing of a process that is
essential for science, which filters and shapes scientific commu-
nications and decides major research funding, has barely deserved
the interest of researchers. Some research groups have tried to
assess the effect on the quality of peer review of training evaluators
[24], blinding and unmasking [25–27], referee characteristics and
Table 3. Mean initial individual quality scores assessed by two blinded evaluators on the Goodman scale (lowest = 1, highest = 5).
Number of manuscripts is specified when that item did not apply to all manuscripts. Standard deviations ranged from 0.9 to 1.5.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
INITIAL QUALITY SCORES
Group C CS CK CSK ALL
G 1b Lack of Oversight or Fake 3.3 3.3 3.6 3.6 3.5
G 1c Organization 3.3 3.4 3.5 3.2 3.3
G 1d Style 2.7 2.8 3.2 3.2 3.0
G 1e Concise 2.9 2.6 3.0 2.8 2.8
I 2a Background 3.0 3.4 3.7 3.6 3.4
I 2b Aims 3.0 3.1 3.6 3.1 3.2
MM 3a Setting and Source 3.3 2.9 3.2 3.2 3.1
MM 3b Eligibility Criteria 2.9 3.0 3.0 2.9 3.0
MM 3c Suitability of the comparison groups 24 2.0 21 2.3 18 2.5 18 2.7 81 2.3
MM 4a Study Design 2.5 2.9 2.9 24 2.9 114 2.8
MM 4b Sample size rationale 1.2 29 1.2 25 1.5 24 1.3 110 1.3
MM 4c Masking 25 1.1 21 1.8 21 1.3 19 1.4 86 1.4
MM 5a Major variables 2.9 2.9 3.0 3.4 3.0
MM 5b Side-effects 12 1.8 13 1.6 7 3.1 12 2.3 44 2.1
R 6a Lost to follow up 2.2 29 2.0 27 2.3 2.1 113 2.2
R 6b Sample description 2.6 2.6 3.0 2.9 2.8
R 6c Dropouts Description 2.5 2.6 2.9 24 2.6 114 2.6
R 7a Quantitative Methods 2.3 2.4 2.5 2.6 2.4
R 7b Clear Reporting 2.8 2.6 3.2 3.1 2.9
R 7c Reporting of Denominators 2.9 3.3 27 3.3 3.5 114 3.2
R 7d Effect Size 26 2.3 26 2.1 26 2.3 22 2.4 100 2.2
R 7e Diagnostic tests 7 2.6 7 2.0 6 2.7 4 3.0 24 2.5
R 7f Confidence Intervals 1.7 1.9 1.8 2.0 1.9
R 7g Balanced between detail and summary 2.6 2.5 2.9 3.0 2.7
R 7h Dropouts Analisys 24 1.5 19 1.7 16 1.4 15 1.5 74 1.5
R 7i Analisys Multiple Measures 27 2.3 24 2.4 24 2.3 19 2.3 94 2.4
R 7j Report Multiple Measures 20 2.3 16 2.5 17 2.4 15 2.4 68 2.4
R 7k Subgroup Effects 31 2.5 29 2.5 27 2.4 2.5 112 2.5
R 7l Figures&Tables 2.2 1.8 2.5 2.4 2.2
D 8a New Knowledge in its field 2.0 1.9 2.4 2.4 2.2
D 8b Other Supporting Evidence 2.5 2.8 2.9 2.9 2.8
D 8c Limitations of the study 1.8 1.6 1.9 1.9 1.8
D 8d Generalizing 2.1 1.8 2.3 2.4 2.1
D 8e Strength and Tone 2.1 2.1 2.3 2.4 2.2
O 9a Title 2.8 2.4 3.1 3.2 2.9
O 9b Abstract 31 2.8 29 2.6 3.1 2.8 113 2.8
doi:10.1371/journal.pone.0000332.t003..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
Peer Review Improves Quality
PLoS ONE | www.plosone.org 5 March 2007 | Issue 3 | e332
Figure 2. Mean quality changes, with uncertainty confidence intervals, from initial version to final version of the full Goodman scale. The overall
quality is computed by the addition of the scores obtained in each one of the 36 items of the scale (first item is a summarizing measure of quality and
thus, not included). The two groups without a statistical reviewer had a final-initial difference of 4.5 and 4.7 points, equivalent to a final-initial change
in one item from very poor to excellent. Indeed, the two groups with a methodological referee changed 9.1 and 11.3, more than a complete reversal
in the evaluation of two items. Thus, the effect size of adding a statistical reviewer is computed as the weighted average of the changes in groups
CS+CSK minus changes in C+CK.
doi:10.1371/journal.pone.0000332.g002
Figure 3. Intervention effects on overall Goodman Scale. Solid boxes indicate statistically significant effects.
doi:10.1371/journal.pone.0000332.g003
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publication language [28], and feedback by editors [29]. Some
assessed the blinding effect on the acceptance of papers, either in
randomized [30] or non-randomized comparisons [31]. Others
analyzed, in a historical cohort, the report of ‘‘positive’’ findings
[32]. Schriger et al studied the changes after peer review and
editing in tables and figures in a cohort of 62 randomized clinical
trials submitted to BMJ [33]. However, only the randomized
retrospective evaluation of Goodman et al [23] and the paired
comparison of Pierie et al [34] measured reporting quality. A
systematic review undertaken in 2002 concluded ‘‘Peer review,
although widely used, is largely untested and its effects are
uncertain’’ [35]. Our searches in Medline found only one (although
non-randomized) study, suggesting that a statistical checklist could
improve report quality [36]. Surprisingly, very few studies have
analyzed the true outcome of peer review: manuscript quality
instead of review quality. Although it is possible to think of further
indicators of research quality, perhaps related to positive impact
[37], the MQAI [23] has the advantage of being the only scale
developed out of a randomized study that measures reporting
quality and can be applied to a broad set of studies. As far as we
know, this is the first prospective randomized trial assessing the
effect of peer review to have a positive result. In 2001 we carried
out a similar study on 43 manuscripts to estimate the effect of
reviewers, which was significant in several secondary variables, but
not in the principal, although this did show a trend towards
a positive effect [38]. Those results encouraged us to extensively
review our design and methods. Basically, what we have added to
this new study is a complete follow-up, including those manuscripts
finally rejected, with the analysis of alternative sensitive analyses.
The 14 papers lost to follow-up did not differ, in terms of
baseline quality, from the originals in the complete population. On
the other hand, the 16 rejected papers present a significantly lower
initial score on the overall Goodman scale than the 99 accepted
papers. However, we have to be careful when interpreting these
results as the two evaluators, although blinded to the intervention
group, knew the editorial decision-as they didn’t have the final
manuscript version.
For this study we have concentrated on the quantitative results.
We do not provide qualitative information about what the
statistical reviewers actually did to improve the manuscripts or
how they differ from clinical reviewers. Furthermore, we did not
study if authors followed all of the reviewer’s suggestions, either
clinical or methodological; or if there are manuscript character-
istics related to potential improvement introduced by peer review.
It should also be stressed that our target population was a single
journal with an impact factor of just over 1: external validity of our
results may be compromised if the positive effect of including
a methodological reviewer depends upon journal, paper or
reviewer characteristics. If journals with higher impact factors
have better methodological papers [39], their room for improve-
ment may be lower. But on the other hand, it could also be
considered that those journals may also have better methodolog-
ical reviewers.
We did not find statistical significance on the effect of enclosing
a Spanish checklist [17] and suggesting English reporting guide-
lines such us CONSORT or STARD to Spanish reviewers.
Unfortunately, because referees were not asked to return the
Figure 4. Estimated effect of statistical review over the 36 Goodman
items. Solid boxes indicate statistically significant effects. 1 Differences
in improvement from baseline between groups with and without
statistical reviewer
doi:10.1371/journal.pone.0000332.g004
Figure 5. Estimated effect of checklist suggestion on the 36
Goodman items. Solid boxes indicate statistically significant effects. 1
Differences in improvement from baseline between groups with and
without checklist suggestion
doi:10.1371/journal.pone.0000332.g005
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completed checklists, we are not able to determine if they
employed the proper guide for the study reviewed or if they
misused the guide. It is very difficult to interpret the negative result
in the intervention subgroup. In terms of alpha risk consumption
and regression to the mean (since baseline quality was higher for
group 3) both may lead to an erroneous conclusion, but as very
few studies were randomized clinical trials and most of them were
before-after studies, without well-known guidelines, a negative
effect may have been produced. In any event, the fact that the
evaluators were able to guess the presence of the reporting
guideline in 65.3% (95% CI: 53.5 to 76.0%) of papers suggests the
need for a new trial with an improvement in checklist delivery and
feedback.
Here we have shown scientific evidence that peer review has
a positive effect on the final quality of papers, by means of
demonstrating, in a randomized trial with masked evaluation, the
effects of adding a methodological expert to the review panel.
Nonetheless, there is still a long way to go to ensure that scientific
communications achieve the maximum quality. Even, if peer
review is not the last system to improve research or, at least, to
improve scientific journals and reporting [40].
SUPPORTING INFORMATION
Text S1 Authors and reviewers agreement
Found at: doi:10.1371/journal.pone.0000332.s001 (0.02 MB
DOC)
Text S2 Goodman scale
Found at: doi:10.1371/journal.pone.0000332.s002 (0.11 MB
DOC)
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